NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/05/2025
Back to search
Official data from USPTO
ATOSSA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/05/2025
Trademark type
Combined
Nice classes
42
Filing date
11/15/2024
Registration date
08/05/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/05/2025
Last transaction
08/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/01/2018
First use in commerce
10/01/2018
Drawing code
3
Owner type
03
Owner location
Seattle, WA, US
Examiner
JOHNSON, BRITTANY S
Law office
N80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "ATOSSA THERAPEUTICS" next to a drawing of a partial face.
Holders and representatives
Holders
Atossa Therapeutics, Inc.
Representatives
Margaret McHugh KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research in the field of pharmaceutical development; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/17/2025
PUBO
PUBLISHED FOR OPPOSITION
06/17/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/14/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
05/14/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/14/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
05/14/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/14/2025
DOCK
ASSIGNED TO EXAMINER
05/12/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/08/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/08/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/13/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/13/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/13/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/13/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/13/2025
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
01/27/2025
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
01/27/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/17/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/17/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/17/2025
NWAP
NEW APPLICATION ENTERED
11/15/2024
Continuous trademark protection
Get notified about every new filing that threatens ATOSSA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.